Review: In rheumatoid arthritis, TNF-α inhibitors do not differ from placebo or DMARDs for all-cause mortality.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      A review of the article "All-cause Mortality Associated with TNF-alpha Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials," by L. Poiroux et. al, which appeared in the periodical American Journal of Medicine on December 3, 2015 is presented.